Biblio Discovery — Demo Discovery Service

37 hasil untuk "Moritz Binder"

Menampilkan 1–20 · 0,88 detik · RSS

  1. Artikel Jurnal

    Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes

    Moritz Binder; Raphael E. Szalat; Srikanth Talluri dkk.

    Nature Communications, Vol. 15 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract The natural history of multiple myeloma is characterized by its localization to the bone marrow and its interaction with bone marrow stromal cells. The bone marrow stromal cells provide growth and survival signals, thereby promoting the development of drug resistance. Here, we show that…

  2. Artikel Jurnal

    Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations

    Saurabh Zanwar; Joseph Novak; Wilson Gonsalves dkk.

    Blood Advances, Vol. 9 No. 15 · 2025 · Inggris · DOAJ Scopus

    Abstract: Extramedullary disease (EMD) is associated with an inferior prognosis and lower response rates to conventional multiple myeloma (MM)–directed therapies compared to MM without EMD. A deeper understanding of the molecular landscape and underlying drivers of EMD is essential to identify…

  3. Artikel Jurnal

    Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide

    Aleksey Mitev; Lisa Christ; Daria Feldmann dkk.

    Arthritis Research & Therapy, Vol. 21 No. 1 · 2019 · Inggris · DOAJ Scopus

    Abstract Background/purpose Elevated levels of C-reactive protein (CRP) in systemic sclerosis (SSc) have been linked to early inflammatory stages of the disease. This study has been designed to investigate CRP levels longitudinally in a cohort of SSc patients and to correlate these findings with…

  4. Artikel Jurnal

    The ratio of brain to liver glucose activity and disease activity in multiple myeloma

    Sarah Dingli; Paul Rothweiler; Moritz Binder dkk.

    Blood Cancer Journal, Vol. 15 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Changes in metabolic activity in tumor cells is one of the hallmarks of cancer. Cancer cells exhibit the Warburg effect with high glucose consumption for their energy needs. This provides the basis for imaging using 18F-2-deoxy-D-glucose for positron emission tomography to assess tumor…

  5. Artikel Jurnal

    Mode of progression in smoldering multiple myeloma: a study of 406 patients

    Nadine H. Abdallah; Arjun Lakshman; Shaji K. Kumar dkk.

    Blood Cancer Journal, Vol. 14 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract The approach to patients with high-risk smoldering multiple myeloma (SMM) varies among clinicians; while some advocate early intervention, others reserve treatment at progression to multiple myeloma (MM). We aimed to describe the myeloma-defining events (MDEs) and clinical presentations…

  6. Artikel Jurnal

    Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia

    Moritz Binder; Ryan M. Carr; Terra L. Lasho dkk.

    Nature Communications, Vol. 13 No. 1 · 2022 · Inggris · DOAJ Scopus

    ‘Mutations in the chromatin remodeler ASXL1 (ASXL1MT) are associated with poor clinical outcome, however, their impact on chromatin dynamics remains unexplored. Here the authors use a multi-omics approach for chronic myelomonocytic leukemia (CMML) and investigate the transcriptome and chromatin…

  7. Artikel Jurnal

    From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis

    Eli Muchtar; Angela Dispenzieri; Francis K. Buadi dkk.

    Blood Advances, Vol. 9 No. 16 · 2025 · Inggris · DOAJ Scopus

    Abstract: This retrospective analysis examined 15 years of autologous stem cell transplantation (ASCT) for light chain (AL) amyloidosis at the Mayo Clinic (2010-2024). We aimed to assess ASCT utilization trends, factors influencing practice changes, and current indications amid newer therapies…

  8. Artikel Jurnal

    Long-term outcomes of allogeneic stem cell transplant in multiple myeloma

    Walker M. Schmidt; Nirosha D. Perera; Francis K. Buadi dkk.

    Blood Cancer Journal, Vol. 13 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Allogeneic stem cell transplant (allo SCT) for multiple myeloma (MM) is potentially curative in some, while toxic in many others. We retrospectively analyzed 85 patients diagnosed with MM who underwent allo SCT as frontline or salvage therapy between 2000 and 2022 at Mayo Clinic Rochester…

  9. Artikel Jurnal

    Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic response

    Matthew J. Rees; Susan Geyer; Binoy Yohannan dkk.

    Haematologica, Vol. 999 No. 1 · 2025 · Inggris · DOAJ Scopus

    Cardiac response (CarR) is associated with survival in AL amyloidosis, but substantial variation exists in response kinetics. We investigated variables associated with deep CarRs to characterize the factors that govern organ recovery. Retrospective study of newly-diagnosed AL amyloidosis patients…

  10. Artikel Jurnal

    CAR T-cell therapy outcomes in plasma cell leukemia

    Melinda Tan; Joselle Cook; Wilson I. Gonsalves dkk.

    Blood Immunology & Cellular Therapy, Vol. 2 No. 1 · 2026 · Inggris · DOAJ

    Abstract: Plasma cell leukemia (PCL) is a rare and aggressive plasma cell disorder with poor outcomes. We retrospectively evaluated 26 patients with primary PCL (n = 21) or secondary PCL (n = 5) treated with anti–B-cell maturation antigen–directed chimeric antigen receptor T-cell (CAR-T…

  11. Artikel Jurnal

    Conditional survival in multiple myeloma and impact of prognostic factors over time

    Nadine H. Abdallah; Alexandra N. Smith; Susan Geyer dkk.

    Blood Cancer Journal, Vol. 13 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Overall survival estimates from diagnosis are valuable for guiding treatment, but do not consider the years already survived. Conditional survival (CS) provides dynamic survival predictions over time. This study was conducted to estimate CS at 1–8 years from diagnosis and the impact of…

  12. Artikel Jurnal

    Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis

    Elham Askari; Angela Dispenzieri; Francis K. Buadi dkk.

    Blood Cancer Journal, Vol. 15 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Uniform assessment of response to treatment is crucial to managing multiple myeloma (MM) and developing new therapies. Measurement of monoclonal protein forms the cornerstone of disease assessment in MM. According to International Myeloma Working Group (IMWG) guidelines, serum-free light…

  13. Artikel Jurnal

    Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide

    Utkarsh Goel; Charalampos Charalampous; Prashant Kapoor dkk.

    Blood Cancer Journal, Vol. 14 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Refractoriness to lenalidomide is an important factor determining the choice of therapy at first relapse in multiple myeloma (MM). It remains debatable if resistance to lenalidomide varies among MM refractory to standard doses vs low dose maintenance doses. In this study, we assessed the…